Seeing Fujifilm's efforts to see the Samsung business
Japan's Fujifilm is relying on the development of drug-transfer drugs, salted fish turned over, Samsung (Samsung) also intends to do the same? Korean media reported that Samsung got a professor at Seoul National University report on global trends, find new growth momentum, reportedly will focus on the future development of health care services, with the intention singular (General Electric), Siemens (Siemens) cooperation, create a new day.
The Korea Times reported that the top three of the Samsung Group gathered in the Seocho building in Seoul on the 3rd to hold a weekly meeting to hear a lecture by Park Tae-hyun, a professor at Seoul National University. Park called on Samsung to continue investing in biotechnology and related businesses to achieve sustainable development. Samsung has reportedly selected biosimilars, medical devices, automobiles, solar cells, LEDs, etc. as the main growth engine for future revenue.
In terms of health care, it is said that Samsung has negotiated alliances with the United States and Siemens in Germany; Samsung has also actively acquired and purchased many medical-related companies.
Yonhap News reported that Samsung announced on November 25 that it will cooperate with Thermo Fisher Scientific in the United States to expand its market share in the medical industry. Samsung will supply a variety of point-of-care equipment, which will be sold by Thermo Fisher Scientific. The key care inspection equipment allows patients to immediately detect medical data in clinics, ambulances, homes, etc., without having to go through traditional laboratories.
Barron's reported on November 5 that Credit Suisse reported that biosimilar drugs have recently reached a market value of $70 billion, with anti-tumor necrosis factor (Anti-TNF) being highly regarded. The companies most likely to benefit from the first wave of anti-TNF growth include Samsung, Novartis, Pfizer and others.
China Peptide Bpc 157 Powder,Dostinex Breastfeeding Powder supplier & manufacturer, offer low price, high quality Bpc-157 Peptide Powder,Anabolic Follistati 344 Powder, etc.
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.
For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.
Peptide Bpc 157 Powder,Dostinex Breastfeeding Powder,Bpc-157 Peptide Powder,Anabolic Follistati 344 Powder
Xi'an Hollysince Biotech Co., Ltd. , https://www.hollysince.com